PRESS RELEASE published on 12/19/2025 at 07:30, 4 months 26 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la 44ème conférence annuelle J.P. Morgan Healthcare Conference à San Francisco du 12 au 15 janvier 2026 pour présenter ses avancées en thérapies auditives Biotechnologie Conference J.P. Morgan Sensorion Thérapies Auditives
BRIEF published on 09/17/2025 at 07:35, 7 months 27 days ago Sensorion announces its 2025 half-year results Funding Gene Therapy SENS-401 SENS-501 2025 Results
BRIEF published on 09/17/2025 at 07:35, 7 months 27 days ago Sensorion annonce ses résultats semestriels 2025 Financement Thérapie Génique SENS-401 SENS-501 Résultats 2025
PRESS RELEASE published on 09/17/2025 at 07:30, 7 months 27 days ago Inside Information / News release on accounts, results Sensorion reports 2025 half-year results, corporate update, and availability of half-year report. Progress in gene therapy programs for hearing loss disorders discussed Clinical Trials Gene Therapy Sensorion Hearing Loss Disorders 2025 Half-Year Results
PRESS RELEASE published on 09/17/2025 at 07:30, 7 months 27 days ago Informations privilégiées / Communiqué sur comptes, résultats Sensorion présente ses résultats du premier semestre 2025, activités de thérapie génique SENS-501, GJB2-GT et SENS-401, annonce dépôts réglementaires et études cliniques en cours Résultats Thérapie Génique Études Cliniques Dépôts Réglementaires Sensorion
BRIEF published on 09/04/2025 at 07:35, 8 months 10 days ago Sensorion to Present at 60th Inner Ear Biology Workshop Biotechnology Gene Therapy Sensorion Hearing Loss Inner Ear Biology Workshop
BRIEF published on 09/04/2025 at 07:35, 8 months 10 days ago Sensorion présentera au 60e atelier sur la biologie de l'oreille interne Biotechnologie Thérapie Génique Sensorion Perte Auditive Atelier De Biologie De L'oreille Interne
PRESS RELEASE published on 09/04/2025 at 07:30, 8 months 10 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la 60ème conférence annuelle Inner Ear Biology Workshop pour présenter ses avancées en thérapie génique pour la perte auditive Thérapie Génique Sensorion Perte Auditive Biologie Oreille Interne 60ème Conférence
PRESS RELEASE published on 09/04/2025 at 07:30, 8 months 10 days ago Inside Information / Other news releases Sensorion announces participation in the 60th Annual Inner Ear Biology Workshop presenting gene therapy research for hearing loss disorders Research Gene Therapy Sensorion Hearing Loss Disorders Inner Ear Biology Workshop
BRIEF published on 08/15/2025 at 07:35, 8 months 30 days ago Sensorion Renforce son Contrat de Liquidité avec Kepler Cheuvreux Euronext Biotechnologie Kepler Cheuvreux Liquidité Sensorion
Published on 05/14/2026 at 08:00, 10 minutes ago Touchstone Exploration Reports First Quarter 2026 Results and Operational Update
Published on 05/14/2026 at 04:15, 3 hours 55 minutes ago Battery X Metals Announces Corporate Awareness Engagement
Published on 05/14/2026 at 03:15, 4 hours 55 minutes ago Jaguar Delivers Strong Adjusted Earnings and Strategic Production Restart of MTL (Turmalina Mine) in Q1 2026
Published on 05/14/2026 at 07:50, 20 minutes ago RBI publishes voluntary public tender offer for all Addiko shares at EUR 26.50 per share
Published on 05/14/2026 at 07:00, 1 hour 10 minutes ago Brockhaus Technologies AG: Revenue in Q1 2026 for the continuing and discontinued operations totaled €47.9 million, with adjusted EBITDA of €7.6 million
Published on 05/14/2026 at 03:20, 4 hours 50 minutes ago TCL Electronics (01070.HK) Maintains Strong Growth in Q1 2026
Published on 05/14/2026 at 01:05, 7 hours 5 minutes ago THE ROYAL MINT SHINES A LIGHT ON PINK FLOYD WITH FIRST EVER UK COMMEMORATIVE COIN
Published on 05/13/2026 at 18:02, 14 hours 8 minutes ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 14 hours 10 minutes ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
Published on 05/13/2026 at 17:45, 14 hours 25 minutes ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
